In our study, we have segmented the synthetic biology market by product, technology and application. On the basis of product, the market is segmented into enzymes, oligonucleotides, chassis organisms and xeno-nucleic acids. Enzymes acquired the largest market due to increasing applications of enzymes in industries, medical, food and agriculture. Additionally, enzymes are produced from the microbial sources that are used for industrial and commercial use On the basis of technology, the market is segmented into gene synthesis, genome engineering, measurement and modeling, cloning and sequencing, nanotechnology, and others. In 2017, gene synthesis held the largest market share among the technologies. On the basis of application, global synthetic biology market is segmented into industrial applications, food and agriculture, medical applications, environmental applications, and others.
The synthetic biology market is estimated to account for US$ 56,044.9 Mn by the end of 2025, escalating at a CAGR of 28.2% during the forecast period from 2018 to 2025, rising from US$ 8,244.8 Mn in 2017.
Increasing number of synthetic biology startup companies in developed regions such as, North America and Europe, and growing awareness about wide range of applications of synthetic biology are the major factors contributing to the growth of the market. Additionally, the growth is also governed by new product launches, partnerships, product approvals and collaborations by key players in the market. Additionally, the industry has attracted investments from various global leaders. For instance, synthetic biology company Zymergen has have received US$44 million funds in the year 2015, from investors such as Transcript, AME Cloud Ventures, Data Collective, Draper Fisher Jurvetson, HVF, Innovation Endeavors, Obvious ventures, True Ventures and Two Sigma Ventures. In addition, in the year 2016, Zymergen has raised US$130 million in Series B funding which was led by SoftBank Group.
North America is the largest market for synthetic biology across the globe whose growth in mainly driven by increasing focus on synthetic biology technologies such as gene synthesis and genome editing. Additionally, growing investments by the major companies and technological advancements in the field of genomics, and higher acceptance by the consumers also contribute to the growth of the market in North America. While, Asia Pacific is expected to exhibit fastest growth with China being the largest market followed by Japan and India. In China, the growth of the market is attributed to an increasing number of initiatives in synthetic biology such as launch of synthetic biology association and rising awareness about genome engineering and research and development.
The market for synthetic biology consists of well-recognized organizations as well as emerging companies namely; ThermoFisher Scientific Inc., Merck KGaA, Novozymes, Agilent Technologies, Amyris, GenScript, Integrated DNA Technologies, Inc., Twist Bioscience, New England Biolabs, Synthetic Genomics Inc. and others.
TABLE OF CONTENTS
1. INTRODUCTION 17
1.1 SCOPE OF THE STUDY 17
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 17
2. GLOBAL SYNTHETIC BIOLOGY MARKET – KEY TAKEAWAYS 18
3. GLOBAL SYNTHETIC BIOLOGY MARKET – MARKET LANDSCAPE 21
3.1 OVERVIEW 21
3.2 MARKET SEGMENTATION 21
3.3 GLOBAL SYNTHETIC BIOLOGY MARKET – BY PRODUCT 22
3.4 GLOBAL SYNTHETIC BIOLOGY MARKET – BY TECHNOLOGY 22
3.5 GLOBAL SYNTHETIC BIOLOGY MARKET – BY APPLICATION 23
3.6 GLOBAL SYNTHETIC BIOLOGY MARKET – BY GEOGRAPHY 23
3.7 PEST ANALYSIS 24
3.7.1 North America – PEST Analysis 24
3.7.2 Europe – PEST Analysis 26
3.7.3 Asia Pacific – PEST Analysis 28
3.7.4 Middle East & Africa – PEST Analysis 30
3.7.5 South & Central America – PEST Analysis 32
4. GLOBAL SYNTHETIC BIOLOGY MARKET – KEY MARKET DYNAMICS 34
4.1 KEY MARKET DRIVERS 34
4.1.1 Increasing Investments for Synthetic Biology 34
4.1.2 Technological Advancements 34
4.1.3 Rising Numbers of Start-up Companies 35
4.2 KEY MARKET RESTRAINTS 35
4.2.1 Renewed Regulations for Biotechnology 35
4.3 KEY MARKET OPPORTUNITIES 36
4.3.1 Company initiatives in Synthetic Biology Market 36
4.4 FUTURE TRENDS 36
4.4.1 Advanced Synthetic Biology 36
4.5 IMPACT ANALYSIS 37
5. GLOBAL SYNTHETIC BIOLOGY MARKET – GLOBAL 38
5.1 GLOBAL SYNTHETIC BIOLOGY MARKET REVENUE FORECASTS AND ANALYSIS 38
5.2 GLOBAL SYNTHETIC BIOLOGY MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 39
5.3 MARKET POSITIONING 40
5.4 PERFORMANCE OF KEY PLAYERS 40
5.4.1 Merck KGaA 40
5.4.2 ThermoFisher Scientific Inc. 41
5.5 CLINICAL TRIALS ANALYSIS 41
5.5.1 Phase I Clinical Trails 42
5.5.2 Phase II Clinical Trails 43
5.6 EXPERT OPINIONS 43
6. GLOBAL SYNTHETIC BIOLOGY MARKET ANALYSIS– BY PRODUCT 44
6.1 OVERVIEW 44
6.2 ENZYMES 44
6.2.1 Overview 44
6.2.2 Global Enzymes Market Revenue and Forecasts to 2025 (US$ Mn) 45
6.3 OLIGONUCLEOTIDES 46
6.3.1 Overview 46
6.3.2 Global Oligonucleotides Market Revenue and Forecasts to 2025 (US$ Mn) 46
6.4 CHASSIS ORGANISMS 47
6.4.1 Overview 47
6.4.2 Global Chassis Organisms Market Revenue and Forecasts to 2025 (US$ Mn) 47
6.5 XENO-NUCLEIC ACIDS 48
6.5.1 Overview 48
6.5.2 Global Xeno-nucleic acids Market Revenue and Forecasts to 2025 (US$ Mn) 48
7. GLOBAL SYNTHETIC BIOLOGY MARKET ANALYSIS– BY TECHNOLOGY 49
7.1 OVERVIEW 49
7.2 GENE SYNTHESIS 49
7.2.1 Overview 49
7.2.2 Global Gene Synthesis Market Revenue and Forecasts to 2025 (US$ Mn) 50
7.3 GENOME ENGINEERING 51
7.3.1 Overview 51
7.3.2 Global Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn) 51
7.4 MEASUREMENT & MODELING 52
7.4.1 Overview 52
7.4.2 Global Measurement & Modeling Market Revenue and Forecasts to 2025 (US$ Mn) 52
7.5 CLONING & SEQUENCING 53
7.5.1 Overview 53
7.5.2 Global Cloning & Sequencing Market Revenue and Forecasts to 2025 (US$ Mn) 53
7.6 NANOTECHNOLOGY 54
7.6.1 Overview 54
7.6.2 Global Nanotechnology Market Revenue and Forecasts to 2025 (US$ Mn) 54
7.7 OTHERS 55
7.7.1 Overview 55
7.7.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn) 55
8. GLOBAL SYNTHETIC BIOLOGY MARKET ANALYSIS– BY APPLICATION 56
8.1 OVERVIEW 56
8.2 INDUSTRIAL APPLICATIONS 56
8.2.1 Overview 56
8.2.2 Global Industrial Applications Market Revenue and Forecasts to 2025 (US$ Mn) 57
8.3 FOOD & AGRICULTURE 58
8.3.1 Overview 58
8.3.2 Global Food & Agriculture Market Revenue and Forecasts to 2025 (US$ Mn) 58
8.4 MEDICAL APPLICATIONS 59
8.4.1 Overview 59
8.4.2 Global Medical Applications Market Revenue and Forecasts to 2025 (US$ Mn) 59
8.5 ENVIRONMENTAL APPLICATIONS 60
8.5.1 Overview 60
8.5.2 Global Environmental Applications Market Revenue and Forecasts to 2025 (US$ Mn) 60
8.6 OTHERS 61
8.6.1 Overview 61
8.6.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn) 61
9. NORTH AMERICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 62
9.1 OVERVIEW 62
9.1.1 North America Synthetic Biology Market Revenue and Forecasts to 2025 (US$ Mn) 62
9.2 U.S. SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
9.3 CANADA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
9.4 MEXICO SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 69
10. EUROPE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 71
10.1 OVERVIEW 71
10.2 UK SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
10.3 GERMANY SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
10.4 FRANCE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
11. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 80
11.1 OVERVIEW 80
11.2 CHINA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
11.3 JAPAN SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
11.4 INDIA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 87
12. MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 89
12.1 OVERVIEW 89
12.2 U.A.E. SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
12.3 SAUDI ARABIA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 94
12.4 SOUTH AFRICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
13. SOUTH AND CENTRAL AMERICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 98
13.1 OVERVIEW 98
13.2 BRAZIL SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
14. SYNTHETIC BIOLOGY MARKET –INDUSTRY LANDSCAPE 103
14.1 OVERVIEW 103
14.2 GROWTH STRATEGIES IN THE SYNTHETIC BIOLOGY MARKET, 2016-2018 103
14.3 ORGANIC GROWTH STRATEGIES 104
14.3.1 Overview 104
14.4 ORGANIC GROWTH STRATEGIES IN THE SYNTHETIC BIOLOGY MARKET, 2016-2018 104
14.5 PRODUCT LAUNCH 105
14.5.1 Recent Product Launches by Players in the Synthetic Biology market 105
14.6 PRODUCT APPROVALS 105
14.6.1 Recent Product Approvals by Players in the Synthetic Biology market 105
14.7 OTHERS 106
14.7.1 Recent Other Strategies by Players in the Synthetic Biology market 106
14.8 INORGANIC GROWTH STRATEGIES 107
14.8.1 Overview 107
14.8.2 Partnership & Collaboration 108
14.8.3 Agreements 108
14.8.4 Acquisitions 109
14.9 JOINT VENTURES 109
15. SYNTHETIC BIOLOGY MARKET –KEY COMPANY PROFILES 110
15.1 THERMOFISHER SCIENTIFIC INC. 110
15.1.1 Key Facts 110
15.1.2 Business Description 110
15.1.3 Financial Overview 111
15.1.4 Product Portfolio 111
15.1.5 SWOT Analysis 112
15.1.6 Key Developments 113
15.2 AGILENT TECHNOLOGIES 114
15.2.1 Key Facts 114
15.2.2 Business Description 114
15.2.3 Financial Overview 115
15.2.4 Product Portfolio 115
15.2.5 SWOT Analysis 116
15.2.6 Key Developments 118
15.3 MERCK KGAA 119
15.3.1 Key Facts 119
15.3.2 Business Description 119
15.3.3 Financial Overview 120
15.3.4 Product Portfolio 120
15.3.5 SWOT Analysis 121
15.3.6 Key Developments 122
15.4 NEW ENGLAND BIOLABS 124
15.4.1 Key Facts 124
15.4.2 Business Description 124
15.4.3 Financial Overview 124
15.4.4 Product Portfolio 124
15.4.5 SWOT Analysis 125
15.4.6 Key Developments 126
15.5 SYNTHETIC GENOMICS, INC. 127
15.5.1 Key Facts 127
15.5.2 Business Description 127
15.5.3 Financial Overview 127
15.5.4 Product portfolio 127
15.5.5 SWOT ANALYSIS 128
15.5.6 KEY DEVELOPMENTS 129
15.6 AMYRIS 131
15.6.1 Key Facts 131
15.6.2 Business Description 131
15.6.3 Financial Overview 131
15.6.4 Product Portfolio 132
15.6.5 SWOT Analysis 132
15.6.6 Key Developments 133
15.7 INTEGRATED DNA TECHNOLOGIES, INC. 134
15.7.1 Key Facts 134
15.7.2 Business Description 134
15.7.3 Financial Overview 134
15.7.4 Product Portfolio 134
15.7.5 SWOT Analysis 135
15.7.6 Key Developments 136
15.8 TWIST BIOSCIENCE 137
15.8.1 Key Facts 137
15.8.2 Business Description 137
15.8.3 Financial Overview 137
15.8.4 Product portfolio 137
15.8.5 SWOT ANALYSIS 138
15.8.6 KEY DEVELOPMENTS 139
15.9 GENSCRIPT 140
15.9.1 Key Facts 140
15.9.2 Business Description 140
15.9.3 Financial Overview 141
15.9.4 Product Portfolio 141
15.9.5 SWOT Analysis 142
15.9.6 Key Developments 143
15.10 NOVOZYMES 144
15.10.1 Key Facts 144
15.10.2 Business Description 144
15.10.3 Financial Overview 145
15.10.4 Product portfolio 145
15.10.5 SWOT ANALYSIS 146
15.10.6 KEY DEVELOPMENTS 147
16. APPENDIX 148
16.1 ABOUT THE INSIGHT PARTNERS 148
16.2 GLOSSARY OF TERMS 149
16.3 METHODOLOGY 150
16.4 COVERAGE 150
16.5 SECONDARY RESEARCH 151
16.6 PRIMARY RESEARCH 151
LIST OF TABLES
TABLE 1. PHASE I CLINICAL TRAILS 42
TABLE 2. PHASE II CLINICAL TRAILS 43
TABLE 3. NORTH AMERICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 63
TABLE 4. NORTH AMERICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 63
TABLE 5. NORTH AMERICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 64
TABLE 6. US SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 65
TABLE 7. US SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 66
TABLE 8. US SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 66
TABLE 9. CANADA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 67
TABLE 10. CANADA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 68
TABLE 11. CANADA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 68
TABLE 12. MEXICO SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 69
TABLE 13. MEXICO SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 70
TABLE 14. MEXICO SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 70
TABLE 15. EUROPE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 72
TABLE 16. EUROPE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 72
TABLE 17. EUROPE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 73
TABLE 18. UK SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 74
TABLE 19. UK SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 74
TABLE 20. UK SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 75
TABLE 21. GERMANY SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 76
TABLE 22. GERMANY SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 77
TABLE 23. GERMANY SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 77
TABLE 24. FRANCE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 79
TABLE 25. FRANCE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 79
TABLE 26. FRANCE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79
TABLE 27. ASIA PACIFIC SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 81
TABLE 28. ASIA PACIFIC SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 81
TABLE 29. ASIA PACIFIC SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 82
TABLE 30. CHINA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 83
TABLE 31. CHINA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 84
TABLE 32. CHINA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 84
TABLE 33. JAPAN SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 86
TABLE 34. JAPAN SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 86
TABLE 35. JAPAN SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 86
TABLE 36. INDIA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 87
TABLE 37. INDIA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 88
TABLE 38. INDIA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 88
TABLE 39. MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 90
TABLE 40. MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 90
TABLE 41. MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 91
TABLE 42. UAE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 92
TABLE 43. UAE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 93
TABLE 44. UAE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 93
TABLE 45. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 94
TABLE 46. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 95
TABLE 47. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 95
TABLE 48. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 96
TABLE 49. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 97
TABLE 50. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
TABLE 51. SOUTH & CENTRAL AMERICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 99
TABLE 52. SOUTH & CENTRAL AMERICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 99
TABLE 53. SOUTH & CENTRAL AMERICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100
TABLE 54. BRAZIL SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 101
TABLE 55. BRAZIL SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN) 102
TABLE 56. BRAZIL SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 102
TABLE 57. RECENT PRODUCT LAUNCHES IN THE SYNTHETIC BIOLOGY MARKET 105
TABLE 58. RECENT PRODUCT APPROVALS IN THE SYNTHETIC BIOLOGY MARKET 105
TABLE 59. RECENT OTHER STRATEGIES IN THE SYNTHETIC BIOLOGY MARKET 106
TABLE 60. RECENT PARTNERSHIPS & COLLABORATIONS IN THE SYNTHETIC BIOLOGY MARKET 108
TABLE 61. RECENT AGREEMENTS IN THE SYNTHETIC BIOLOGY MARKET 108
TABLE 62. RECENT ACQUISITIONS IN THE SYNTHETIC BIOLOGY MARKET 109
TABLE 63. RECENT JOINT VENTURES IN THE SYNTHETIC BIOLOGY MARKET 109
TABLE 64. GLOSSARY OF TERMS, SYNTHETIC BIOLOGY MARKET 149
LIST OF FIGURES
FIGURE 1. ASIA PACIFIC SYNTHETIC BIOLOGY MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 18
FIGURE 2. GLOBAL SYNTHETIC BIOLOGY MARKET BY PRODUCT, MARKET SHARE (%), 2017 19
FIGURE 3. GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY, MARKET SHARE (%), 2017 19
FIGURE 4. GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATION, MARKET SHARE (%), 2017 20
FIGURE 5. SYNTHETIC BIOLOGY MARKET SEGMENTATION 21
FIGURE 6. SYNTHETIC BIOLOGY MARKET SEGMENTATION, BY REGION 22
FIGURE 7. NORTH AMERICA PEST ANALYSIS 24
FIGURE 8. EUROPE PEST ANALYSIS 26
FIGURE 9. ASIA PACIFIC PEST ANALYSIS 28
FIGURE 10. MIDDLE EAST & AFRICA PEST ANALYSIS 30
FIGURE 11. SOUTH & CENTRAL AMERICA PEST ANALYSIS 32
FIGURE 12. SYNTHETIC BIOLOGY MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 37
FIGURE 13. GLOBAL SYNTHETIC BIOLOGY MARKET – REVENUE FORECASTS AND ANALYSIS – 2016- 2025 38
FIGURE 14. GLOBAL SYNTHETIC BIOLOGY MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025 39
FIGURE 15. GLOBAL SYNTHETIC BIOLOGY MARKET – KEY MARKET PLAYERS 40
FIGURE 16. GLOBAL SYNTHETIC BIOLOGY MARKET BREAKDOWN, BY PRODUCT 2017 & 2025 (%) 44
FIGURE 17. GLOBAL ENZYMES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 18. GLOBAL OLIGONUCLEOTIDES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
FIGURE 19. GLOBAL CHASSIS ORGANISMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
FIGURE 20. GLOBAL XENO-NUCLEIC ACIDS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
FIGURE 21. GLOBAL SYNTHETIC BIOLOGY MARKET BREAKDOWN, BY TECHNOLOGY 2017 & 2025 (%) 49
FIGURE 22. GLOBAL GENE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
FIGURE 23. GLOBAL GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
FIGURE 24. GLOBAL MEASUREMENT & MODELING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
FIGURE 25. GLOBAL CLONING & SEQUENCING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
FIGURE 26. GLOBAL NANOTECHNOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 27. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
FIGURE 28. GLOBAL SYNTHETIC BIOLOGY MARKET BREAKDOWN, BY APPLICATION 2017 & 2025 (%) 56
FIGURE 29. GLOBAL INDUSTRIAL APPLICATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
FIGURE 30. GLOBAL FOOD & AGRICULTURE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
FIGURE 31. GLOBAL MEDICAL APPLICATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
FIGURE 32. GLOBAL ENVIRONMENTAL APPLICATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
FIGURE 33. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 34. NORTH AMERICA SYNTHETIC BIOLOGY MARKET OVERVIEW, BY COUNTRY (2017) 62
FIGURE 35. NORTH AMERICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
FIGURE 36. NORTH AMERICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 64
FIGURE 37. US SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 65
FIGURE 38. CANADA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
FIGURE 39. MEXICO SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 69
FIGURE 40. EUROPE SYNTHETIC BIOLOGY MARKET OVERVIEW, BY COUNTRY (2017) 71
FIGURE 41. EUROPE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72
FIGURE 42. EUROPE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 73
FIGURE 43. UK SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 74
FIGURE 44. GERMANY SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
FIGURE 45. FRANCE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
FIGURE 46. ASIA PACIFIC SYNTHETIC BIOLOGY MARKET OVERVIEW, BY COUNTRY (2017) 80
FIGURE 47. ASIA PACIFIC SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
FIGURE 48. ASIA PACIFIC SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 82
FIGURE 49. CHINA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
FIGURE 50. JAPAN SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
FIGURE 51. INDIA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 87
FIGURE 52. MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET OVERVIEW, BY COUNTRY (2017) 89
FIGURE 53. MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 90
FIGURE 54. MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY 91
FIGURE 55. UAE SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
FIGURE 56. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 94
FIGURE 57. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
FIGURE 58. SOUTH AND CENTRAL AMERICA SYNTHETIC BIOLOGY MARKET OVERVIEW, BY COUNTRY (2017) 98
FIGURE 59. SOUTH & CENTRAL AMERICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
FIGURE 60. SOUTH & CENTRAL AMERICA SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 100
FIGURE 61. BRAZIL SYNTHETIC BIOLOGY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
FIGURE 62. GROWTH STRATEGIES IN THE SYNTHETIC BIOLOGY MARKET, 2016-2018 103
FIGURE 63. ORGANIC GROWTH STRATEGIES IN THE SYNTHETIC BIOLOGY MARKET, 2016-2018 104
FIGURE 64. INORGANIC GROWTH STRATEGIES IN THE SYNTHETIC BIOLOGY MARKET, 2016-2018 107
The List of Companies:
1. Thermo Fisher Scientific Inc.
2. Merck KGaA
3. Novozymes
4. Agilent Technologies
5. Amyris
6. GenScript
7. Integrated DNA Technologies, Inc.
8. Twist Bioscience
9. New England Biolabs
10. Synthetic Genomics Inc.
